DrugFactsBoxes are based on nearly two decades of academic research.
Click on the links below to browse our research:
Read more about DrugFactsBoxes on:
National clinical trials prove that DrugFactsBoxes are effective
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two randomized trials. Annals of Internal Medicine 2009; 150: 516-527
Communicating data about the benefits and harms of treatment: A randomized trial. Annals of Internal Medicine 2011: 155:87-96.
The Drug Facts Box: Providing Consumers with Simple Tabular Data on Drug Benefit and Harm. Medical Decision Making 2007; 27:655-662.
The Drug Facts Box: Improving Communication of Prescription Drug Information. Proceedings of the National Academy of Sciences, 2013.
The Value of Benefit Data in Direct-to-Consumer Drug Ads. Health Affairs 2004; W4:234-245.
Government organizations recognize DrugFactsBoxes
Minutes of the Risk Communication Advisory Committee, FDA
Health Product Risk Communication: Is the Message Getting Through? Council of Canadian Academies
Problems with drug data today
Lost in transmission—FDA Drug Information that Never Reaches Clinicians. New England Journal of Medicine 2009; 361:1717-1720.
Bringing FDA’s information to market. Arch Intern Med 2009; 169:1985-1987.
How the FDA forgot the evidence: The case of donepezil 23mg. BMJ 2012; 344:e1086.
Communicating Uncertainties about Prescription Drugs to the Public: A National Randomized Trial. Arch Intern Med 2011; 1717:1463-1468.
Overdiagnosed. Beacon Press; 1st edition (January 3, 2012)
Know Your Chances: Understanding Health Statistics. University of California Press, 2008